Unique ID issued by UMIN | UMIN000031682 |
---|---|
Receipt number | R000029575 |
Scientific Title | Clinical trials to evaluate the effectiveness of lingonberry and amla fruit extract intake |
Date of disclosure of the study information | 2018/03/14 |
Last modified on | 2018/06/15 08:37:33 |
Clinical trials to evaluate the effectiveness of lingonberry and amla fruit extract intake
Clinical trials to evaluate the effectiveness of lingonberry and amla fruit extract intake
Clinical trials to evaluate the effectiveness of lingonberry and amla fruit extract intake
Clinical trials to evaluate the effectiveness of lingonberry and amla fruit extract intake
Japan |
The healthy female who feels decline of the skin condition
Dermatology |
Others
NO
Effect of improving skin condition by the intake of lingonberry and amla fruit extract is evaluated in a randomized, double-blind, placebo-controlled trial.
Efficacy
The elasticity of the skin is measured four times for 12 weeks every four weeks.
The following measurement item is measured four times for 12 weeks every four weeks.
1. Skin thickness
2. Stratum corneum hydration
3. Epidermal and dermal hydration
4. Clinical evaluation of wrinkle
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
3
Treatment
Food |
In the placebo group, the placebo drink must take in every day for 12 weeks.
The placebo beverage is prepared with the same amounts of sweetener, sour seasoning and flavor as test beverage, so that they will not differ in taste from each other.
The test beverage of "the lingonberry and amla fruit extract (LAE) single dose drink" must take in every day for 12 weeks.
The test beverage of "LAE double dose drink" must take in every day for 12 weeks.
35 | years-old | <= |
50 | years-old | >= |
Female
1.Healthy females from 35 years old to 50 years old
2.Individuals conscious of skin roughness by drying
3.Individuals who has felt an effect on skin by the intake of the supplement
4.Individuals who feels a decrease of the elasticity of the skin
5. Individuals who does not use a supplement and a drug regularly now
6. Individuals who abstain from drinking alcohol from the day before measurement to the measurement end
7. Individuals who agree to participate in the study
8. Individuals judged appropriate for the study by attendant physician
1.Individuals with abnormalities of skin areas planned to be tested
2.Individuals considered likely to develop allergy to the test substance (Individuals with food allergy)
3.Individuals with chronic cutis symptoms such as atopic dermatitis
4.Patients receiving drug therapy as outpatients
5.Individuals participating in other studies within the past 3 months
6.Habitual smokers
7.Patients with asthma
8.Pregnant women, women desiring to become pregnant, or lactating women
9.Individuals having used cosmetics or the like possessing moisture-retaining effects on the skin areas planned to be tested in this study within 1 month before the start of the study
10.Individuals taking or intending to take drugs against pollinosis
11.Individuals judged inappropriate for the study by attending physician
90
1st name | |
Middle name | |
Last name | Masashi Ogo |
SHISEIDO CO., LTD.
Life Science Reserch Center
2-2-1,Hayabuchi,Tsuzuki-ku, YOKOHAMA, KANAGAWA-ken 224-0025, Japan
045-590-6000
masashi.ogo@to.shiseido.co.jp
1st name | |
Middle name | |
Last name | Kazunori Takashima |
Inforward, Inc
Ebisu Skin Research Center
1-11-2 Ebisu, Shibuya, Tokyo 1500013, Japan
03-5447-6411
takashima@inforward.co.jp
SHISEIDO CO., LTD.
None
Self funding
NO
2018 | Year | 03 | Month | 14 | Day |
Unpublished
Completed
2015 | Year | 11 | Month | 13 | Day |
2015 | Year | 11 | Month | 25 | Day |
2016 | Year | 05 | Month | 19 | Day |
2016 | Year | 05 | Month | 20 | Day |
2016 | Year | 09 | Month | 30 | Day |
2018 | Year | 03 | Month | 12 | Day |
2018 | Year | 06 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029575